ERBB2 and neoplasm: Hyperactivation of AKT1 is observed in over 50% of human tumors [51], and our previous study demonstrated that AKT1 plays a central role in transducing oncogenic signals (including, PI3K, Ras and Her2) to promote tumor metastasis by suppressing ΔNp63α expression [14].